About this trial
This prospective randomized controlled trial will compare ejaculation-preserving bipolar transurethral enucleation of the prostate with standard bipolar transurethral enucleation of the prostate in sexually active men with benign prostatic hyperplasia and lower urinary tract symptoms after failed medical treatment. Participants will be randomly assigned to either ejaculation-preserving B-TUEP or standard B-TUEP. The study will evaluate preservation of ejaculatory function, erectile function, urinary symptom improvement, uroflowmetry outcomes, post-void residual urine, perioperative complications, and need for retreatment during follow-up.
Eligibility criteria
Qualifiers
Male patients with lower urinary tract symptoms secondary to benign prostatic obstruction after failed medical treatment for at least 3 months.
Sexually active patients with a continuous relationship with the same partner.
International Prostate Symptom Score of 8 or greater.
Transrectal ultrasound-estimated prostate size between 40 and 100 cc.
Disqualifiers
Preoperative sexual dysfunction.
Preoperative ejaculatory dysfunction.
Diagnosis or suspicion of prostate cancer.
Neurological disorders affecting lower urinary tract or sexual function.
Trial design
Treatments tested in this trial
- Ejaculation-Preserving Bipolar Transurethral Enucleation of the Prostate
- Standard Bipolar Transurethral Enucleation of the Prostate